Related Experiment Video

Updated: May 18, 2026

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
08:06

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

Prospects of personalized medicine in cardiovascular diseases

Claude Lenfant1

  • 1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. lenfantc@prodigy.net

Metabolism: Clinical and Experimental
|September 25, 2012
PubMed

Insights

Advances in genetic research identify cardiovascular disease variants, paving the way for personalized medicine. Challenges remain in explaining genetic risk and implementing these personalized cardiovascular strategies.

Area of Science:

  • Genetics and Genomics
  • Cardiovascular Medicine
  • Personalized Medicine

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Genetic and genomic research, including genome-wide association studies (GWAS), has identified numerous genetic variants linked to cardiovascular traits and diseases.
  • Despite progress, clinical applications are limited due to unexplained genetic risk and unknown mechanisms.

Purpose of the Study:

  • To present the current status of personalized medicine for cardiovascular disease.
  • To discuss the future prospects of personalized cardiovascular medicine.
  • To explore implementation challenges for personalized cardiovascular medicine.

Main Methods:

  • Review of recent advances in human genetic and genomic research.
  • Analysis of genome-wide association studies (GWAS) in cardiovascular disease.
  • Discussion of the concept and application of personalized medicine in cardiology.

Main Results:

  • Identification of numerous genetic variants associated with cardiovascular traits and diseases.
  • Emergence of personalized medicine as a concept driven by genetic discoveries.
  • Recognition of limitations in current clinical application and understanding of genetic factors.

Conclusions:

  • Genetic research has significantly advanced the concept of personalized cardiovascular medicine.
  • Further research is needed to elucidate genetic risk mechanisms and improve clinical utility.
  • Successful implementation of personalized cardiovascular medicine requires addressing practical and scientific challenges.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...